Cite
HARVARD Citation
Henderson, M. et al. (n.d.). Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial. Lancet oncology. 16 (9), pp. 1049-1060. [Online].